全文获取类型
收费全文 | 1966篇 |
免费 | 103篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 15篇 |
儿科学 | 49篇 |
妇产科学 | 60篇 |
基础医学 | 365篇 |
口腔科学 | 123篇 |
临床医学 | 202篇 |
内科学 | 332篇 |
皮肤病学 | 32篇 |
神经病学 | 124篇 |
特种医学 | 66篇 |
外科学 | 339篇 |
综合类 | 14篇 |
预防医学 | 112篇 |
眼科学 | 8篇 |
药学 | 136篇 |
中国医学 | 2篇 |
肿瘤学 | 98篇 |
出版年
2023年 | 9篇 |
2022年 | 22篇 |
2021年 | 31篇 |
2020年 | 23篇 |
2019年 | 23篇 |
2018年 | 28篇 |
2017年 | 33篇 |
2016年 | 31篇 |
2015年 | 37篇 |
2014年 | 38篇 |
2013年 | 68篇 |
2012年 | 113篇 |
2011年 | 92篇 |
2010年 | 67篇 |
2009年 | 71篇 |
2008年 | 121篇 |
2007年 | 121篇 |
2006年 | 139篇 |
2005年 | 131篇 |
2004年 | 125篇 |
2003年 | 103篇 |
2002年 | 110篇 |
2001年 | 30篇 |
2000年 | 20篇 |
1999年 | 22篇 |
1998年 | 25篇 |
1997年 | 15篇 |
1996年 | 33篇 |
1995年 | 15篇 |
1994年 | 20篇 |
1993年 | 16篇 |
1992年 | 12篇 |
1991年 | 16篇 |
1990年 | 14篇 |
1989年 | 12篇 |
1988年 | 12篇 |
1987年 | 19篇 |
1986年 | 14篇 |
1985年 | 11篇 |
1984年 | 11篇 |
1983年 | 9篇 |
1982年 | 7篇 |
1981年 | 8篇 |
1980年 | 11篇 |
1937年 | 9篇 |
1929年 | 7篇 |
1928年 | 11篇 |
1926年 | 8篇 |
1925年 | 7篇 |
1922年 | 6篇 |
排序方式: 共有2077条查询结果,搜索用时 0 毫秒
61.
A murine model of minor histocompatibility antigen (miHCag)-mismatched bone marrow transplantation (BMT) was used to study the development of immunoregulatory cells in the posttransplantation period and their possible involvement in the dissociated graft-versus-host (GVH) and graft-versus-leukemia (GVL) reactivity of posttransplantation donor lymphocyte infusions (DLIs). DLI, applied immediately after BMT, induced GVH disease (GVHD), but when DLI was delayed for 3 weeks, GVHD was avoided while a distinct GVL response was allowed to develop. A population of Mac1+Ly6-G+Ly6-C+ immature myeloid cells, found in small numbers in normal mice, strongly expanded in spleens of chimeras, reaching a maximum level at week 3 and returning to base level by week 12. Upon isolation, these cells exhibited interferon-gamma (IFN-gamma)-dependent, nitric oxide (NO)-mediated suppressor activity toward in vitro alloresponses, suggesting that, after in vivo DLI, they are activated by IFN-gamma to produce NO and suppress GVH reactivity. Because not only alloactivated T-cell proliferation but also leukemia cell growth was found susceptible to inhibition by exogenous NO, in vivo activation of these cells after DLI may explain the occurrence of a GVL effect despite suppression of GVHD. This suggested sequence of events was supported by the finding that the ex vivo antihost proliferative response of spleen cells, recovered shortly after in vivo DLI, was characterized by strong mRNA production of the monokines interleukin-1 (IL-1), IL-6, and tumor necrosis factor-alpha (TNF-alpha) and of inducible nitric oxide synthase (iNOS). Our data suggest that transiently expanding Mac1+Ly6-G+Ly6-C+ immature myeloid cells (probably as a result of extramedullary myelopoiesis) may play a role in controlling GVH while promoting GVL reactivity of DLI after allogeneic BMT. 相似文献
62.
Kevin Willy Gerrit Frommeyer Dirk G. Dechering Kristina Wasmer Dennis Höwel Sarah S. Welle Nils Bögeholz Christian Ellermann Julian Wolfes Benjamin Rath Patrick R. Leitz Julia Köbe Philipp S. Lange Patrick Müller Florian Reinke Lars Eckardt 《Clinical cardiology》2020,43(12):1423-1427
BackgroundAblation emerged as first line therapy in the treatment of various arrhythmias. Nevertheless, in older patients (pts), decision is often made pro drug treatment as more complications and less benefit are suspected.HypothesisWe hypothesized that different kind of ablations can be performed safely regardless of the pts age.MethodsWe enrolled all pts aged >80 years (yrs) who underwent ablation for three different arrhythmias (atrial flutter [AFL], atrioventricular nodal re‐entry tachycardia [AVNRT], ventricular tachycardia [VT]) between August 2002 and December 2018. Procedural data and outcome were compared with matched groups aged 60 to 80 years and 40 to 60 years, respectively. Periprocedural and in‐hospital complications were analyzed.ResultsThe analysis included 1191 patients (397 pts per group: 63% AFL, 23% AVNRT, 14% VT) who underwent ablation. Acute success was high in all types of arrhythmias irrespective of age (>80, 60‐80, 40‐60 years: AFL 97%/98%/98%, AVNRT 97%/95%/97%, VT 82%/86%/93%). Rate of periprocedural complications were similar in all groups treated for AFL and AVNRT. For VT ablations significant differences were noted between pts > 80 or 60 to 80 years and those aged 40‐60 years (16.1%/14.3%/3.6%). Most complications were infections and groin haematoma. No strokes, iatrogenic atrioventricular blocks and deaths related to the ablation occurred.ConclusionAblation appears safe in pts > 80 years. Success rates were comparable to matched younger cohorts. A significant difference was observed for VT patients. 相似文献
63.
64.
65.
Mark P. Mattson David B. Allison Luigi Fontana Michelle Harvie Valter D. Longo Willy J. Malaisse Michael Mosley Lucia Notterpek Eric Ravussin Frank A. J. L. Scheer Thomas N. Seyfried Krista A. Varady Satchidananda Panda 《Proceedings of the National Academy of Sciences of the United States of America》2014,111(47):16647-16653
Although major research efforts have focused on how specific components of foodstuffs affect health, relatively little is known about a more fundamental aspect of diet, the frequency and circadian timing of meals, and potential benefits of intermittent periods with no or very low energy intakes. The most common eating pattern in modern societies, three meals plus snacks every day, is abnormal from an evolutionary perspective. Emerging findings from studies of animal models and human subjects suggest that intermittent energy restriction periods of as little as 16 h can improve health indicators and counteract disease processes. The mechanisms involve a metabolic shift to fat metabolism and ketone production, and stimulation of adaptive cellular stress responses that prevent and repair molecular damage. As data on the optimal frequency and timing of meals crystalizes, it will be critical to develop strategies to incorporate those eating patterns into health care policy and practice, and the lifestyles of the population. 相似文献
66.
67.
Marija Sevkusic Lena Schuster Lena Rothmund Katharina Dettinger Moritz Maier Reinhard Hickel Kirsten L. Van Landuyt Jürgen Durner Christof Högg Franz-Xaver Reichl 《Dental materials》2014
Objectives
Constituents of dental composites can be released from dental fillings after polymerization. The aim of this study was to examine the time-related elution and breakdown of separable constituents of polymerized composites using deuterated solvents.Method
Elution and breakdown of constituents were investigated with deuterated solvents methanol and water by gas chromatography/mass spectrometry of following composites for 180 days: Filtek™ Supreme XT, Filtek™ Supreme XT Flow, Tetric Ceram®, Tetric Flow®, Grandio®, Grandio® Flow.Results
Within 180 days no compounds were formed as the products of breakdown. 19 compounds were identified as elution products: Bis-EMA, TEGDMA, DDDMA, EGDMA, MAA, BPA, CQ, HQME, DMABEE, CSA, BL, TEG, BHT, TINP, TPP, TPSB, DEDHTP, DCHP, ß-PHEA.The highest concentration of Bis-EMA was measured for Tetric Flow® in deuterated methanol on day 90 at 36.993 mmol/l and in deuterated water also on day 90 at 0.031 mmol/l.The highest TEGDMA concentrations were measured for Grandio® Flow in deuterated methanol on day 60 at 1.322 mmol/l and for Filtek™ Supreme XT Flow in deuterated water on day 3 at 0.689 mmol/l. The highest BPA concentration was measured for Tetric Flow® in deuterated methanol on day 90 at 1.469 mmol/l. The highest BPA concentration was measured for Grandio® in deuterated water on day 180 at 0.007 mmol/l.Significance Examination of time-related elution indicates that various elution products (e.g. Bis-EMA, BPA) were only released in small quantities during the first 90 days, but in high quantities between day 90 and day 180. 相似文献68.
69.
Judith V. E. Hettinga Willy Lemstra Coby Meijer Gerrit Los Elisabeth G. E. de Vries Antonius W. T. Konings Harm H. Kampinga 《International journal of cancer. Journal international du cancer》1996,67(6):800-807
It has been suggested that the expression of certain heat-shock proteins (HSPs) may be prognostic markers in several tumor types. Since HSPs may be involved in determining cellular sensitivity to chemotherapeutic drugs, the possible relation between HSP expression and cisplatin (cDDP) sensitivity was studied. Three human germ-cell tumor cell lines, 1 human small-cell lung carcinoma (SCLC) cell line and 3 human colon carcinoma cell lines were used as a model for differences in intrinsic cDDP sensitivity. The constitutive expression of a panel of HSPs was studied by immunoblotting. No correlation was found between expression of HSP90, HSP73, HSP72, HSP60 and HSP27 and the extent of intrinsic cDDP sensitivity when all cell lines studied were considered. However, for the 3 cell lines derived from germ-cell carcinomas, HSP27 expression was inversely related to cDDP sensitivity, i.e. decreased HSP27 levels were associated with decreased sensitivity. Constitutive HSP expression was also studied in 2 sets of human cell lines with in vitro acquired cDDP resistance. In both resistant cell lines, decreased expression of HSP27 (as determined by Western blotting) was found as compared to the sensitive parent cell lines. Thus, acquired resistance to cDDP was also accompanied by decreased HSP27 expression. Interestingly, when basal HSP27 mRNA levels were measured in the SCLC cell line (GLC4) and its subline with acquired resistance (GLC4-cDDP), no significant differences were detected. Continuous cDDP incubation increased HSP27 levels and induced HSP27 phosphorylation in GLC4 cells, but not in the resistant subline. Thus, although no general relationships between HSP expression and cDDP sensitivity are apparent, high HSP27 expression in vitro relates to high sensitivity to cDDP treatment in some tumor types. This is in accordance with reported clinical data on high HSP27 levels in tumors correlating with good prognosis. © 1996 Wiley-Liss, Inc. 相似文献
70.